International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1,-2, and-3: Pharmacology and Pathophysiological Functions

被引:266
作者
Stoddart, Leigh A. [1 ]
Smith, Nicola J. [1 ]
Milligan, Graeme [1 ]
机构
[1] Univ Glasgow, Mol Pharmacol Grp, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
D O I
10.1124/pr.108.00802
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Identification of G protein-coupled receptors that are activated by free fatty acids has led to considerable interest in their pharmacology and function because of the wide range of normal physiology and disease states in which fatty acids have been implicated. Free fatty acid receptor ( FFA) 1 is activated by medium- to long-chain fatty acids and is expressed in the insulin-producing beta-cells of the pancreas. Activation of FFA1 has been proposed to mediate fatty acid augmentation of glucose-stimulated insulin secretion although it is unclear whether the known long-term detrimental effects of beta-cell exposure to high levels of fatty acids are also mediated through this receptor. The related receptors FFA2 and FFA3 are both activated by short-chain fatty acids although they have key differences in the signaling pathways they activate and tissue expression pattern. The aim of this review is to provide a comprehensive overview of the current understanding of the pharmacology and physiological role of these fatty acid receptors.
引用
收藏
页码:405 / 417
页数:13
相关论文
共 91 条
[11]   Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes [J].
Cavaglieri, CR ;
Nishiyama , A ;
Fernandes, LC ;
Curi, R ;
Miles, EA ;
Calder, PC .
LIFE SCIENCES, 2003, 73 (13) :1683-1690
[12]  
COHEN LA, 1993, NUTR CANCER, V19, P1, DOI 10.1080/01635589309514231
[13]  
Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI13914
[14]   Seven transmembrane-spanning receptors for free fatty acids as therapeutic targets for diabetes mellitus: Pharmacological, phylogenetic, and drug discovery aspects [J].
Costanzi, Stefano ;
Neumann, Susanne ;
Gershengorn, Marvin C. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (24) :16269-16273
[15]   SHORT CHAIN FATTY-ACIDS IN HUMAN LARGE-INTESTINE, PORTAL, HEPATIC AND VENOUS-BLOOD [J].
CUMMINGS, JH ;
POMARE, EW ;
BRANCH, WJ ;
NAYLOR, CPE ;
MACFARLANE, GT .
GUT, 1987, 28 (10) :1221-1227
[16]   The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation [J].
Dass, N. B. ;
John, A. K. ;
Bassil, A. K. ;
Crumbley, C. W. ;
Shehee, W. R. ;
Maurio, F. P. ;
Moore, G. B. T. ;
Taylor, C. M. ;
Sanger, G. J. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 (01) :66-74
[17]   Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis [J].
DeFronzo, RA .
NETHERLANDS JOURNAL OF MEDICINE, 1997, 50 (05) :191-197
[18]   Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion [J].
Edfalk, Sara ;
Steneberg, Par ;
Edlund, Helena .
DIABETES, 2008, 57 (09) :2280-2287
[19]   Saturated fatty acids synergize with elevated glucose to cause pancreatic β-cell death [J].
El-Assaad, W ;
Buteau, J ;
Peyot, ML ;
Nolan, C ;
Roduit, R ;
Hardy, S ;
Joly, E ;
Dbaibo, G ;
Rosenberg, L ;
Prentki, M .
ENDOCRINOLOGY, 2003, 144 (09) :4154-4163
[20]   Ulcerative colitis [J].
Farrell, RJ ;
Peppercorn, MA .
LANCET, 2002, 359 (9303) :331-340